Atlas Trials

Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

Clinical trial NCT00781170 · COMPLETED

Trial details

NCT number
NCT00781170
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaStem Cell Transplantation
Start date
2000-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.